CL vs FDMT · P/E 34, rev $20.38B vs rev $37.0K
Colgate-Palmolive Company (CL) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the CL and FDMT stock pages for the full models.
Not investment advice.